Corrigendum to “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway”
Joint Authors
Yang, Chul Woo
Hong, Yu Ah
Park, Ki Cheol
Yang, Keum Jin
Jung, So Young
Choi, Hyunsu
Oh, Jeong Min
Lee, Sang Ju
Chang, Yoon Kyung
Kim, Suk Young
Hwang, Hyeon Seok
Park, Cheol Whee
Source
Oxidative Medicine and Cellular Longevity
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-08-13
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway” [1], an acknowledgement should be added as follows:
American Psychological Association (APA)
Hong, Yu Ah& Yang, Keum Jin& Jung, So Young& Park, Ki Cheol& Choi, Hyunsu& Oh, Jeong Min…[et al.]. 2017. Corrigendum to “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway”. Oxidative Medicine and Cellular Longevity،Vol. 2017, no. 2017, pp.1-1.
https://search.emarefa.net/detail/BIM-1193969
Modern Language Association (MLA)
Hong, Yu Ah…[et al.]. Corrigendum to “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway”. Oxidative Medicine and Cellular Longevity No. 2017 (2017), pp.1-1.
https://search.emarefa.net/detail/BIM-1193969
American Medical Association (AMA)
Hong, Yu Ah& Yang, Keum Jin& Jung, So Young& Park, Ki Cheol& Choi, Hyunsu& Oh, Jeong Min…[et al.]. Corrigendum to “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway”. Oxidative Medicine and Cellular Longevity. 2017. Vol. 2017, no. 2017, pp.1-1.
https://search.emarefa.net/detail/BIM-1193969
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1193969
